Therapeutic Goods (Medical Devices—Authorised Supply) Rules 2020

Administered by Department of Health, Disability and Ageing

Legislation au F2020L01174 Rules Not in force Legislative Instrument

Legislation content

Therapeutic Goods (Medical Devices—Authorised Supply) Rules 2020

made under subsection 41HC(6) of the

Therapeutic Goods Act 1989

Compilation No. 1

Compilation date: 11 February 2022

Includes amendments up to: F2022L00123

 

 

About this compilation

This compilation

This is a compilation of the Therapeutic Goods (Medical Devices—Authorised Supply) Rules 2020 that shows the text of the law as amended and in force on 11 February 2022 (the compilation date).

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law.

Application, saving and transitional provisions for provisions and amendments

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the series page on the Legislation Register for the compiled law.

Selfrepealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

 

 

 

 

 

Contents

1  Name

3  Authority

4  Definitions

5  Authorisation

Schedule 1—Medical devices authorised for supply

Endnotes

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

 

 

1  Name

  This instrument is the Therapeutic Goods (Medical Devices—Authorised Supply) Rules 2020.

3  Authority

  This instrument is made under subsection 41HC(6) of the Therapeutic Goods Act 1989.

4  Definitions

Note: A number of expressions used in this instrument are defined in subsection 3(1) of the Act, including the following:

(a) health practitioner;

(b) included in the Register;

(c) medical device;

(d) Register;

(e) sponsor; and

(f) supply.

  In this instrument:

Act means the Therapeutic Goods Act 1989.

SAS Guidance means the document titled Special Access Scheme Guidance for health practitioners and sponsors (Version 1.1, September 2017) published by the Therapeutic Goods Administration, as in force or existing at the commencement of this instrument.

Note: The SAS Guidance is published at www.tga.gov.au.

Therapeutic Goods Administration has the same meaning as in the Therapeutic Goods Regulations 1990.

5  Authorisation

  Supply by a specified health practitioner

 (1) A health practitioner specified in column 4 of an item in the table in Schedule 1 is authorised to supply a kind of medical device to a patient of that practitioner where:

 (a) the kind of medical device is specified in column 2 of that item; and

 (b) the supply is for the purpose specified in column 3 of that item; and

 (c) the conditions specified in subsection (2) are satisfied.

 (2) The health practitioner must:

 (a) inform the patient, or a parent or guardian of the patient, that the kind of medical device is not included in the Register; and

 (b) obtain informed consent from the patient, or a parent or guardian of the patient, in relation to, and before, the supply of the kind of medical device; and

 (c) supply the kind of medical device in accordance with good medical practice; and

 (d) if the health practitioner becomes aware that the patient has suffered an adverse event in relation to the kind of medical device—notify the Therapeutic Goods Administration and the sponsor of the kind of medical device about the adverse event in accordance with the reporting guidelines set out in the SAS Guidance; and

 (e) if the health practitioner becomes aware of a defect in the kind of medical device—notify the Therapeutic Goods Administration and the sponsor of the kind of medical device in accordance with the reporting guidelines set out in the SAS Guidance.

  Supply to a patient of a specified health practitioner

 (3) A health practitioner is authorised to supply a kind of medical device to a patient of a health practitioner specified in column 4 of an item in the table in Schedule 1 (the treating practitioner) where:

 (a) the kind of medical device is specified in column 2 of that item; and

 (b) the supply is requested by the treating practitioner; and

 (c) the supply is for the purpose specified in column 3 of that item; and

 (d) the conditions specified in subsection (4) are satisfied.

 (4) The health practitioner supplying the medical device must:

 (a) if the health practitioner becomes aware that the patient has suffered an adverse event in relation to the kind of medical device—notify the Therapeutic Goods Administration and the sponsor of the kind of medical device about the adverse event in accordance with the reporting guidelines set out in the SAS Guidance; and

 (b) if the health practitioner becomes aware of a defect in the kind of medical device—notify the Therapeutic Goods Administration and the sponsor of the medical device in accordance with the reporting guidelines set out in the SAS Guidance.

Schedule 1—Medical devices authorised for supply

Note: See section 5.

Specified therapeutic goods

Column 1

Column 2

Column 3

Column 4

Item

Kind of medical device

Purpose

Health practitioner

1

14/16 Taper Femoral Heads – Oxinium – Smith & Nephew (71342280 – 71342368)

revision hip arthroplasty

orthopaedic surgeon

2

Aequalis PerForm Plus Reversed Glenoid – Wright Medical

for arthroplasty of the shoulder

orthopaedic surgeon

3

Aequalis PerForm Reversed Glenoid – Wright Medical

for arthroplasty of the shoulder

orthopaedic surgeon

4A

AltiVate Reverse Shoulder system – DJO Global

for arthroplasty of the shoulder

orthopaedic surgeon

5

Biodesign Enterocutaneous Fistula Plug

for repair of enterocutaneous fistulae

general surgeon

6

BlastGen
(Product No. 1205)

culture of embryos from the 4-8 cell stage through to the blastocyst stage; or

embryo transfer

obstetrics and gynaecology specialist

7

CelGro Type I/III collagen scaffold – Orthocell

 

articular cartilage repair: collagen scaffold for use with autologous chondrocyte implantation (ACI) to knee (including patellofemoral) and ankle joint; or

augmentation of rotator cuff tendon repair

orthopaedic surgeon

8

CollaCote Dressing

for haemostasis or to protect the wound surface during dental procedures

dental practitioner

9

CollaPlug Absorbable Collagen Wound Dressing

for haemostasis or to protect the wound surface during dental procedures

dental practitioner

10

CollaTape Absorbable Collagen

for haemostasis or to protect the wound surface during dental procedures

dental practitioner

10A

Duraloc Acetabular Cup System – Hip Insert/Liner – Johnson & Johnson t/a DePuy Synthes

revision hip arthroplasty

orthopaedic surgeon

11

EmbryoGen

(Product No. 1203)

fertilisation and culture until the 2-8 cell stage; or

embryo transfer at day 2 or 3

obstetrics and gynaecology specialist

12

EmbryoGen & BlastGen

(Product No. 1206)

culture of embryos until the 2-8 cell stage (Embryogen) and culture of embryos from the 4-8 cell stage through to the blastocyst stage (Blastgen); or

embryo transfer

obstetrics and gynaecology specialist

13

EmbryoGen  V2

(Product No. 1204)

culture of human embryos until the 2-8 cell stage; or

embryo transfer at day 2 or 3

obstetrics and gynaecology specialist

14

Endotine Forehead

for use in subperiosteal browplasty surgery

plastic surgeon

15

Endotine Midface

for use in subperiosteal midface suspension surgery

plastic surgeon

16

Geistlich Fibro-Gide – Geistlich Pharma

dental filling material

dental practitioner

17

GM508 CultActive

for investigation of fertilization failure after previous ICSI-cycles

obstetrics and gynaecology specialist

18

Ilex Skin Protectant

for use on a variety of dermal wounds and stomal irritations as a topical skin barrier

medical practitioner; nurse practitioner

19

Insall/Burstein II Modular Knee System - Posterior Stabilised Tibial Articular Surface – Zimmer Biomet (00522003101 – 00522003506)

revision knee arthroplasty

orthopaedic surgeon

20

Journey II Bi-Cruciate Stabilized (BCS) Total Knee System - Articular Insert – Smith & Nephew (74027211 – 74027288)

revision knee arthroplasty

orthopaedic surgeon

21

Jupiter Sternal Protection Device

for use following median sternotomy incisions to add a protective layer over the entire cut surfaces of the sternal bone

cardiothoracic surgeon

24

MG II Total Knee System - Tibial Articular Surface – Zimmer Biomet (00511002309 – 00511005323)

revision knee arthroplasty

orthopaedic surgeon

25

M/G Unicompartmental Knee System - Tibial Articulating Surface – Zimmer Biomet

(00578804008 – 00578808014)

revision knee arthroplasty

orthopaedic surgeon

26

Natural Knee II System – Durasul PE Congruent Tibial Insert – Zimmer Biomet (620108809 – 620110916)

revision knee arthroplasty

orthopaedic surgeon

27

NexGen Complete Knee Solution – Cruciate Retaining (CR) Articular Surface – Zimmer Biomet (00597002009 – 00597005020)

revision knee arthroplasty

orthopaedic surgeon

28

NexGen Complete Knee Solution Legacy PS - Articular Surface – Zimmer Biomet (5996-020-09 to 00-5996-022-23 AND 00-5996-030-09 to 00-5996-051-20)

revision knee arthroplasty

orthopaedic surgeon

29

NexGen Complete Knee Solution Mobile Bearing Knee System - Articular Surface – Zimmer Biomet (00594203109 – 00594207217)

revision knee arthroplasty

orthopaedic surgeon

30

NexGen Complete Knee Solution – Posterior Stabilized (PS) Articular Surface – Zimmer Biomet (00598202010 – 00598205123)

revision knee arthroplasty

orthopaedic surgeon

31

Omnifit Crossfire Series II Cup Insert – Stryker Orthopaedics (2041C2240 - 2041C3274)

revision hip arthroplasty

orthopaedic surgeon

31A

Primetech Piezo Micro Manipulator and microinjection pipettes

in vitro fertilisation

obstetrics and gynaecology specialist

32

Pro Osteon® Bone Graft Substitute 200R

for use as a bone graft substitute only for bony voids or gaps that are not intrinsic to the stability of the bony structure

medical practitioner; dental practitioner

33

Pro Osteon® Bone Graft Substitute 500R

for use as a bone graft substitute only for voids or gaps that are not intrinsic to the stability of the bony structure

medical practitioner

34

Quintip Individual Skin Test System

for allergy skin testing using puncture to apply the test extract

medical practitioner

35

Reflection Ceramic Acetabular System - Reflection Biolox Forte Ceramic Acetabular Liner – Smith & Nephew (71338146 – 71338456)

revision hip arthroplasty

orthopaedic surgeon

35A

Regeneten Bioinductive Implant – Bone Anchors with Anthroscopic Delivery System

rotator cuff surgery

orthopaedic surgeon

36

SeleXys Hip System – Inlay Bionit2 – Mathys Orthopaedics (55462803 – 55463612)

revision hip arthroplasty

orthopaedic surgeon

37

Trilogy AB Alternate Bearing Shell Insert – Zimmer Biomet (00640502601 – 00640503206 AND 00641502802 – 00641503206)

revision hip arthroplasty

orthopaedic surgeon

 


Endnotes

Endnote 1—About the endnotes

The endnotes provide information about this compilation and the compiled law.

The following endnotes are included in every compilation:

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

Abbreviation key—Endnote 2

The abbreviation key sets out abbreviations that may be used in the endnotes.

Legislation history and amendment history—Endnotes 3 and 4

Amending laws are annotated in the legislation history and amendment history.

The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.

The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.

Misdescribed amendments

A misdescribed amendment is an amendment that does not accurately describe the amendment to be made. If, despite the misdescription, the amendment can be given effect as intended, the amendment is incorporated into the compiled law and the abbreviation “(md)” added to the details of the amendment included in the amendment history.

If a misdescribed amendment cannot be given effect as intended, the abbreviation “(md not incorp)” is added to the details of the amendment included in the amendment history.

Endnote 2—Abbreviation key

 

ad = added or inserted

o = order(s)

am = amended

Ord = Ordinance

amdt = amendment

orig = original

c = clause(s)

par = paragraph(s)/subparagraph(s)

C[x] = Compilation No. x

    /subsubparagraph(s)

Ch = Chapter(s)

pres = present

def = definition(s)

prev = previous

Dict = Dictionary

(prev…) = previously

disallowed = disallowed by Parliament

Pt = Part(s)

Div = Division(s)

r = regulation(s)/rule(s)

exp = expires/expired or ceases/ceased to have

reloc = relocated

    effect

renum = renumbered

F = Federal Register of Legislation

rep = repealed

gaz = gazette

rs = repealed and substituted

LA = Legislation Act 2003

s = section(s)/subsection(s)

LIA = Legislative Instruments Act 2003

Sch = Schedule(s)

(md) = misdescribed amendment can be given

Sdiv = Subdivision(s)

    effect

SLI = Select Legislative Instrument

(md not incorp) = misdescribed amendment

SR = Statutory Rules

    cannot be given effect

SubCh = SubChapter(s)

mod = modified/modification

SubPt = Subpart(s)

No. = Number(s)

underlining = whole or part not

 

    commenced or to be commenced

 

Endnote 3—Legislation history

 

Name

Registration

Commencement

Application, saving and transitional provisions

Therapeutic Goods (Medical Devices—Authorised Supply) Rules 2020

17 Sep 2020

(F2020L01174)

18 Sep 2020

Therapeutic Goods (Authorised Supply) Amendment (Medicines and Medical Devices) Rules 2022

10 Feb 2022

(F2022L00123)

11 Feb 2022


Endnote 4—Amendment history

 

Provision affected

How affected

s 2.....................

rep LA s 48D

s 6.....................

rep LA s 48C

Sch 1...................

am F2022L00123

Sch 2...................

rep LA s 48C

 

 

Overview

The Therapeutic Goods (Medical Devices—Authorised Supply) Rules 2020 were enacted to provide a regulatory framework for the supply of certain medical devices by specified health practitioners. These rules were made under subsection 41HC(6) of the Therapeutic Goods Act 1989 and aim to ensure the safe and effective use of medical devices not yet included in the Australian Register of Therapeutic Goods (ARTG). The rules outline specific medical devices that authorised health practitioners can supply to their patients, provided certain conditions are met, including informed consent and reporting of adverse events or defects. The Therapeutic Goods Administration oversees the implementation of these rules to protect public health and ensure that medical devices are used safely and effectively.

Scope and Application

The Therapeutic Goods (Medical Devices—Authorised Supply) Rules 2020 applies to the supply of certain medical devices by specified health practitioners, as listed in the schedule of the Rules, for particular purposes. This legislation is applicable at the Commonwealth level and governs the supply of specific medical devices across Australia. The Rules authorise the supply of these devices under certain conditions, such as informing the patient about the device's status in the Register, obtaining informed consent, and adhering to good medical practice. The specified health practitioners must also report any adverse events or defects related to the devices to the Therapeutic Goods Administration and the device's sponsor. The Rules are made under subsection 41HC(6) of the Therapeutic Goods Act 1989 and include amendments up to F2022L00123. The legislation's reach is not restricted by any stated exclusions, exemptions, or thresholds. The Rules may be extended or restricted through subordinate instruments, although no such modifications are noted in the provided text.

Key Provisions

The Therapeutic Goods (Medical Devices—Authorised Supply) Rules 2020, as amended, provide specific authorisation for the supply of certain medical devices. These rules authorise specified health practitioners to supply listed medical devices for specific purposes, provided certain conditions are met. For instance, under Section 5(1), an orthopaedic surgeon can supply certain revision hip arthroplasty devices if they inform the patient that the device is not included in the Register and obtain the patient's informed consent before the supply. The rules also include detailed specifications in Schedule 1, listing the medical devices, their intended purposes, and the authorised health practitioners. These rules impose several obligations on the health practitioners involved in the supply of these medical devices. For example, practitioners must ensure they inform the patient or the patient's guardian that the device is not registered and must obtain informed consent. Additionally, they must adhere to good medical practice during the supply. If the practitioner becomes aware of any adverse events or defects related to the device, they are required to notify the Therapeutic Goods Administration and the device's sponsor, in accordance with the reporting guidelines outlined in the Special Access Scheme Guidance. Breaches of these rules can lead to significant consequences. Although the rules themselves do not explicitly state penalties, violations could lead to actions under the Therapeutic Goods Act 1989, which includes potential criminal penalties for non-compliance. Such penalties might include fines and, in severe cases, imprisonment. Additionally, failure to comply with the reporting requirements could result in civil or administrative penalties, impacting the practitioner's professional standing and the sponsor's reputation.

Legal classification tags

Area of Law
Medical Law
Instrument
Regulation
Concepts
Definitions & Interpretation
Licensing & Registration
Enforcement Powers
Reporting & Disclosure Obligations
Compliance Obligations

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.